BRP
BRP, a BRINP2-related peptide, possesses anti-obesity activity via FOS activation. BRP central FOS activation and acts independently of leptin, GLP-1 receptor and melanocortin 4 receptor[1].
Product Specifications
Product Name Alternative
BRINP2-related peptide
UNSPSC
12352209
Target
AP-1
Related Pathways
Immunology/Inflammation
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Purity
95.15
Solubility
H2O : ≥ 100 mg/mL
Smiles
O=C(N[C@@H](CC1=CNC=N1)C(N[C@@H](CCCNC(N)=N)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(C)C)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(C)C)C(N[C@@H](CS)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H]([C@H](O)C)N
Molecular Formula
C68H117N25O14S
Molecular Weight
1540.88
References & Citations
[1]Laetitia Coassolo, et al. Prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide. Nature. 2025 Mar 5.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15333177 1 Vial
Lentiviral human AATK shRNA (UAS) - Lentiviral human AATK shRNA (UAS) (100)
Sign In for Pricing
View Details 
MBS1079472-01 0.05 mg (E-Coli)
Recombinant Guinea pig Prorelaxin (RLN)
Sign In for Pricing
View Details MBS1079472-02 0.2 mg (E-Coli)
Recombinant Guinea pig Prorelaxin (RLN)
Sign In for Pricing
View Details